Neoleukin Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.About NLTX
Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.
CEOJonathan G. Drachman
CEOJonathan G. Drachman
Employees91
Employees91
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2003
Founded2003
Employees91
Employees91
NLTX Key Statistics
Market cap25.14M
Market cap25.14M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume62.05K
Average volume62.05K
High today—
High today—
Low today—
Low today—
Open price$0.58
Open price$0.58
Volume0.00
Volume0.00
52 Week high$3.84
52 Week high$3.84
52 Week low$0.375
52 Week low$0.375
NLTX Earnings
-$0.30
-$0.20
-$0.10
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 1, After Hours
ActualExpected Mar 1, After Hours